- Home
- BIP vs ICLR Comparison
BIP vs ICLR Comparison
Compare BIP & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BIP | ICLR |
|---|---|---|
| Founded | 2007 | 1990 |
| Country | Bermuda | Ireland |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.4B | 14.3B |
| IPO Year | 2008 | 1998 |
Fundamental Metrics
Financial Performance| Metric | BIP | ICLR |
|---|---|---|
| Price | $35.67 | $185.83 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 14 |
| Target Price | $42.20 | ★ $201.23 |
| AVG Volume (30 Days) | 553.8K | ★ 1.0M |
| Earning Date | 11-07-2025 | 10-22-2025 |
| Dividend Yield | ★ 4.83% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | 0.70 | ★ 7.47 |
| Revenue | ★ $22,240,000,000.00 | $8,102,602,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $0.76 |
| P/E Ratio | $50.74 | ★ $24.87 |
| Revenue Growth | ★ 8.14 | N/A |
| 52 Week Low | $25.72 | $125.10 |
| 52 Week High | $36.58 | $228.29 |
Technical Indicators
Market Signals| Indicator | BIP | ICLR |
|---|---|---|
| Relative Strength Index (RSI) | 54.17 | 62.18 |
| Support Level | $35.32 | $174.13 |
| Resistance Level | $36.58 | $191.15 |
| Average True Range (ATR) | 0.59 | 8.46 |
| MACD | -0.03 | 2.87 |
| Stochastic Oscillator | 49.23 | 85.77 |
Price Performance
Historical ComparisonAbout BIP Brookfield Infrastructure Partners LP
Brookfield Infrastructure Partners LP is a Bermuda exempted limited partnership that owns and operates quality, long-life assets that generate stable cash flows, by virtue of barriers to entry or other characteristics that tend to appreciate in value over time. It focuses on acquiring infrastructure assets that have low maintenance capital costs and high barriers to entry. The company's segments consist of Utilities, Transport, Midstream, and Data. Geographically, it generates maximum revenue from USA and also has a presence in Australia, Colombia, United Kingdom, Brazil, United States of America, Chile, Peru, and other countries.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.